| 3/20/2025 | BKIG | Fitch gives Amgen positive outlook
|
| 8/22/2024 | BKIG | Moody’s revises Amgen outlook to stable
|
| 10/11/2023 | BKGNIG | Fitch trims Amgen
|
| 9/5/2023 | IG | Amgen acquisition of Horizon Therapeutics clears FTC
|
| 2/17/2023 | IG | Market Commentary: High-grade bond issuance jumps; Amgen among record deals; busy week ahead anticipated
|
| 2/16/2023 | IG | New Issue: Amgen sells $24 billion senior note offering in eight parts
|
| 2/15/2023 | BKGNHYIG | Moody’s assigns Amgen notes Baa1
|
| 2/14/2023 | BKGNHYIG | S&P assigns Amgen notes BBB+
|
| 2/14/2023 | BKGNHYIG | Fitch rates Amgen loans, notes BBB+
|
| 2/14/2023 | IG | Amgen to sell fixed-rate notes in eight parts via four bookrunners
|
| 2/13/2023 | BKGNHYIG | Moody’s turns Amgen outlook to negative
|
| 12/13/2022 | BKGNHYIG | S&P puts Horizon on positive watch
|
| 12/13/2022 | BKGNHYIG | Moody's eyes Horizon for upgrade
|
| 12/12/2022 | BKGNHYIG | Moody's eyes Amgen downgrade
|
| 12/12/2022 | BKGNHYIG | S&P snips Amgen
|
| 12/12/2022 | BKIG | Amgen gets $28.5 billion bridge loan commitment for Horizon purchase
|
| 12/12/2022 | BKGNHYIG | Fitch places Amgen on watch
|
| 8/15/2022 | IG | New Issue: Amgen prices $3 billion of senior notes due 2029, 2033, 2053
|
| 8/15/2022 | BKGNIG | S&P gives Amgen notes A-
|
| 8/15/2022 | BKGNIG | Fitch rates Amgen notes BBB+
|
| 8/15/2022 | BKGNIG | Moody's gives Baa1 to Amgen notes
|
| 8/15/2022 | IG | Amgen to sell fixed-rate notes in three parts via four bookrunners
|
| 8/8/2022 | BKGNIG | S&P turns Amgen view to negative
|
| 2/18/2022 | IG | Market Commentary: Investment-grade issuers Amgen, Verizon, DTE, Mizuho price green bonds; paper mostly improves
|
| 2/17/2022 | IG | New Issue: Amgen sells $4 billion of notes in four parts
|
| 2/17/2022 | BKGNIG | Fitch gives Amgen notes BBB+
|
| 2/17/2022 | BKGNIG | S&P rates Amgen notes A-
|
| 2/17/2022 | BKGNIG | Moody's assigns Amgen notes Baa1
|
| 2/17/2022 | GNIG | Amgen to sell fixed-rate notes, including green notes, in four parts
|
| 8/6/2021 | IG | New Issue: Amgen sells $5 billion notes in four parts due 2028, 2032, 2041, 2052
|
| 8/5/2021 | BKIG | Fitch gives Amgen notes BBB+
|
| 8/5/2021 | IG | Amgen to offer senior notes in tranches due 2028, 2032, 2041, 2052; talk emerges
|
| 8/5/2021 | BKIG | Moody's rates Amgen notes Baa1
|
| 8/5/2021 | BKIG | S&P assigns Amgen notes A-
|
| 8/5/2021 | IG | Amgen to offer senior notes in tranches due 2028, 2032, 2041, 2052
|
| 8/14/2020 | IGLM | Amgen sets pricing terms for nine exchange offers, increases cap
|
| 8/13/2020 | IGLM | Amgen gives early results of exchange offers for cash and new notes
|
| 7/30/2020 | BKIG | Moody’s rates Amgen notes Baa1
|
| 7/30/2020 | BKIG | S&P assigns Amgen notes A-
|
| 7/30/2020 | IGLM | Amgen begins nine exchange offers for cash and new notes due 2053
|
| 5/6/2020 | BKIG | Fitch rates Amgen notes BBB+
|
| 5/5/2020 | IG | New Issue: Amgen prices $4 billion four-tranche offering of senior notes
|
| 5/4/2020 | IG | Market Commentary: High-grade supply heavy; Apple, Starbucks, Amgen, Marsh in primary; spreads mostly flat
|
| 5/4/2020 | IG | Moody's downgrades ADO
|
| 5/4/2020 | IG | Moody's downgrades ADO
|
| 5/4/2020 | BKIG | Moody's assigns Amgen notes Baa1
|
| 5/4/2020 | BKIG | S&P rates Amgen notes A-
|
| 5/4/2020 | IG | Market Commentary: Morning Commentary: High-grade supply heavy; Apple, Starbucks, Altria, Amgen on deck
|
| 5/4/2020 | IG | Amgen to price tap of 2027, 2040, 2050 notes, new notes due 2031
|
| 2/21/2020 | IG | Market Commentary: W.W. Grainger prices; strong volume forecast; Citrix, Otis notes firm; Omnicom, Amgen ease
|
| 2/19/2020 | IG | Market Commentary: Otis, BP, Tennessee Gas, Halliburton, KLA, Omnicom, UDR tap primary; SSA supply ahead
|
| 2/19/2020 | IG | Market Commentary: Morning Commentary: Otis, Omnicom, Halliburton, BP, Tennessee Gas, KLA, UDR on tap
|
| 2/18/2020 | IG | Market Commentary: Amgen, MUFG, Mizuho, FirstEnergy, BNP, Republic Services flood primary; Otis eyed
|
| 2/18/2020 | IG | New Issue: Amgen prices $5 billion five-tranche offering of senior notes
|
| 2/18/2020 | IG | Market Commentary: Morning Commentary: Amgen, Mizuho, MUFG, Brookfield, FirstEnergy on tap; Otis eyed
|
| 2/18/2020 | IGLM | Amgen to redeem all 3.45%, 4.1%, 1.85% notes, some 3.875% notes
|
| 2/18/2020 | IG | Amgen offers fixed-rate notes in five parts to fund notes redemption
|
| 11/21/2019 | BKIG | S&P trims Amgen
|
| 11/4/2019 | BKIG | Fitch ups Amgen
|
| 8/26/2019 | BKIG | S&P puts Amgen on negative watch
|
| 1/4/2019 | BKIG | Fitch affirms Amgen
|
| 2/2/2018 | BKIG | Moody’s affirms Amgen
|
| 10/31/2017 | IG | Market Commentary: Lloyds sells $4 billion notes; Celgene, GATX, Philip Morris, Constellation, Amgen price
|
| 10/31/2017 | BKIG | S&P gives Amgen notes A
|
| 10/31/2017 | IG | New Issue: Amgen sells $1 billion of 3.2% 10-year senior notes at 87.5 bps spread
|
| 10/31/2017 | BKIG | Moody’s applies Baa1 to Amgen notes
|
| 10/31/2017 | IG | Market Commentary: Morning Commentary: Lloyds, Celgene, GATX, Philip Morris, Constellation, Amgen bonds on tap
|
| 10/31/2017 | IG | Amgen intends to sell 10-year fixed-rate notes via three bookrunners
|
| 5/9/2017 | BKIG | Fitch applies BBB to Amgen notes
|
| 5/9/2017 | IG | New Issue: Amgen gives details on $3.5 billion five-part issue of senior notes
|
| 5/8/2017 | IG | Market Commentary: Intel, Amgen price notes; Caterpillar sells add-on in reverse inquiry; utilities bring bonds
|
| 5/8/2017 | IG | New Issue: Amgen prices $3.5 billion of senior notes in five tranches
|
| 5/8/2017 | BKIG | S&P rates Amgen notes A
|
| 5/8/2017 | BKIG | Moody’s applies Baa1 to Amgen notes
|
| 5/8/2017 | IG | Market Commentary: Morning Commentary: Intel, Caterpillar, Amgen in deal pipeline; Amgen notes modestly better
|
| 5/8/2017 | IG | Amgen intends to sell fixed- and floating-rate notes in five parts
|
| 8/25/2016 | IG | Market Commentary: NextEra prices $500 million; primary thins; Old Republic tightens; credit spreads flat
|
| 8/25/2016 | IG | Market Commentary: Morning Commentary: NextEra remarkets; Old Republic firms; Amgen eases; credit spreads flat
|
| 8/24/2016 | IG | Market Commentary: Swedish Export Credit, Symphony bring bonds; credit spreads ease; Visa, Westpac Banking firm
|
| 8/24/2016 | IG | Market Commentary: Morning Commentary: Primary action set; Westpac Banking, Amgen firm; Libor yield rises
|
| 8/12/2016 | IG | Market Commentary: Morning Commentary: Amgen, Bunge notes tighten in secondary market; credit spreads leak wider
|
| 8/11/2016 | BKCVIG | Fitch rates Amgen notes BBB
|
| 8/11/2016 | IG | New Issue: Amgen details pricing of $3.75 billion senior notes in four tranches
|
| 8/10/2016 | IG | Market Commentary: Amgen, FMS, Baxter among high-grade issuers; credit spreads soften; Duke Energy bonds improve
|
| 8/10/2016 | IG | New Issue: Amgen prices $3.75 billion of senior notes in four tranches
|
| 8/10/2016 | BKIG | Moody’s assigns Baa1 to Amgen notes
|
| 8/10/2016 | BKIG | S&P rates Amgen notes A
|
| 8/10/2016 | IG | Amgen intends to price five-, seven- and 10-year senior notes and 4.4% notes due 2045
|
| 6/10/2016 | IGLM | Amgen to issue $1.42 billion of 4.563% notes, $3.54 billion of 4.663% notes in exchange
|
| 5/25/2016 | IGLM | Amgen prices exchange offers for seven series of notes
|
| 5/13/2016 | BKIG | Fitch assigns BBB to Amgen notes
|
| 5/13/2016 | BKIG | Moody’s rates Amgen notes Baa1
|
| 5/13/2016 | IGLM | Amgen to issue new notes due 2048, 2051 in exchange for seven series
|
| 5/13/2016 | BKIG | S&P rates Amgen notes A
|
| 2/23/2016 | BKIG | S&P rates Amgen bonds A
|
| 2/23/2016 | BKIG | Moody’s rates Amgen notes Baa1
|
| 2/23/2016 | BKIG | Fitch assigns BBB to Amgen notes
|
| 2/18/2016 | BKIG | S&P rates Amgen notes A
|
| 2/18/2016 | BKIG | Moody’s assigns Amgen notes Baa1
|
| 2/18/2016 | BKIG | Fitch rates Amgen notes BBB
|
| 7/15/2015 | BKIG | Fitch lifts Amgen to stable
|
| 5/4/2015 | IG | Market Commentary: Morning Commentary: Amgen, Oracle bonds improve in early trade; strong supply on tap for week
|
| 5/1/2015 | IG | Market Commentary: Scotiabank adds on; Oracle bonds tighten; spreads mixed overall; busy May predicted
|
| 4/29/2015 | IG | Market Commentary: United Technologies prices subordinated notes wide of talk; Oracle, Amgen bonds widen
|
| 4/28/2015 | IG | Market Commentary: Oracle brings $10 billion offering; Amgen, DaVinciRe also price; bank paper mostly flat
|
| 4/28/2015 | BKIG | S&P assigns A to Amgen notes
|
| 4/28/2015 | IG | New Issue: Amgen sells $3.5 billion of senior notes in four tranches
|
| 4/28/2015 | BKIG | Moody's rates Amgen notes Baa1
|
| 4/28/2015 | BKIG | Fitch applies BBB to Amgen notes
|
| 4/28/2015 | IG | Amgen expected to price four-part offering of senior notes
|
| 11/17/2014 | IG | Market Commentary: Morning Commentary: High-grade credit spreads flat ahead of issuance; Citigroup, Amgen soft
|
| 11/7/2014 | BKIG | Moody’s changes Amgen to stable
|
| 5/19/2014 | IG | Market Commentary: Amgen brings $4.5 billion; Nasdaq prices wide; DirecTV tightens; AT&T mostly better
|
| 5/19/2014 | BKIG | Moody's assigns Amgen notes Baa1
|
| 5/19/2014 | IG | New Issue: Amgen prices $4.5 billion of senior notes in five tranches
|
| 5/19/2014 | IG | Amgen pricing benchmark five-part offering of senior notes Monday
|
| 5/19/2014 | IG | Market Commentary: Midday Commentary: Investment-grade spreads unchanged; JPMorgan flat; AT&T better
|
| 5/19/2014 | IG | S&P gives A to Amgen notes
|
| 5/19/2014 | BKIG | Fitch rates Amgen notes BBB
|
| 8/27/2013 | BKIG | S&P cuts Amgen, debt to A
|
| 8/27/2013 | BKIG | Fitch: Amgen view to negative
|
| 8/26/2013 | BKIG | Amgen plans $8.1 billion of bank loans to finance Onyx acquisition
|
| 8/26/2013 | CVIG | Moody's: Amgen view negative
|
| 9/10/2012 | BKCVIG | Moody's rates Amgen notes Baa1
|
| 9/10/2012 | BKCVIG | Fitch rates Amgen notes BBB
|
| 9/10/2012 | BKCVIG | S&P rates Amgen notes A+
|
| 5/31/2012 | BKCVIG | S&P lifts health companies
|
| 5/11/2012 | IG | New Issue: Amgen prices $3 billion of notes in five-, 10-, 31-year tranches
|
| 5/11/2012 | IG | Market Commentary: Amgen, Sweden give terms; $25 billion or more expected in coming week; bank paper widens
|
| 5/10/2012 | CVIG | Fitch rates Amgen bonds BBB
|
| 5/10/2012 | CVIG | Moody's rates Amgen notes Baa1
|
| 5/10/2012 | CVIG | S&P rates Amgen notes A+
|
| 5/10/2012 | IG | Market Commentary: Amgen, Discovery, Beam do multi-tranche sales as tone rebounds; Beam tightens; banks improve
|
| 11/30/2011 | CVIG | Moody's: Amgen notes Baa1
|
| 11/30/2011 | CVIG | S&P rates Amgen notes A+
|
| 11/21/2011 | IG | Market Commentary: IBRD reopens short bond, volatility halts issuance; financials trade wider in light volume
|
| 11/14/2011 | CVIG | Fitch rates Amgen bonds BBB
|
| 11/8/2011 | IG | New Issue: Amgen prices $6 billion of senior notes in four tranches
|
| 11/8/2011 | IG | Market Commentary: International Paper brings $1.5 billion; Halliburton sells $1 billion; HP firms; Hershey flat
|
| 11/7/2011 | CVIG | Fitch downgrades Amgen
|
| 11/7/2011 | CVIG | Moody's cuts Amgen
|
| 11/7/2011 | CVIG | S&P rates Amgen notes A+
|
| 11/7/2011 | IG | Amgen to offer $6 billion of senior notes in four tranches
|
| 11/7/2011 | IG | Market Commentary: Canadian Railway, Zimmer bring deals; Jefferies bucks sector weakness; telecom bonds widen
|
| 10/25/2011 | CVIG | Moody's: Amgen view negative
|
| 7/1/2011 | IG | Market Commentary: Second-quarter issuance starts strong, ends weak; trading slows; financials, new bonds firm
|
| 6/28/2011 | IG | Market Commentary: HSBC, National Retail sell as Greece austerity vote looms; Nokia 15 bps better; telecoms firm
|
| 6/27/2011 | CVIG | S&P rates Amgen notes A+
|
| 6/27/2011 | CVIG | Moody's rates Amgen notes A3
|
| 6/27/2011 | CVIG | Fitch rates Amgen notes A-
|
| 6/27/2011 | IG | New Issue: Amgen prices $3 billion of five, 10-, 31-year senior notes
|
| 6/27/2011 | IG | Market Commentary: Amgen monster deal, Carpenter, Kilroy among those in volatile primary; Amgen long bonds wider
|
| 5/3/2011 | CVIG | Fitch cuts Amgen
|
| 4/28/2011 | CVIG | Moody's cuts Amgen to stable
|
| 3/4/2011 | CVIGPF | Amgen files automatic shelf for stock, preferreds and debt securities
|
| 3/1/2011 | CVIG | Fitch affirms Amgen
|
| 9/15/2010 | IG | Market Commentary: Cliffs Natural, Blackstone, Harsco, JPMorgan, Wyndham among sellers; Amgen notes widen
|
| 9/13/2010 | CVIG | Fitch rates Amgen notes A
|
| 9/13/2010 | IG | Amgen to price $1.5 billion in 10-, 30-year senior unsecured notes
|
| 9/13/2010 | IG | New Issue: Amgen prices $1.5 billion 10-, 31-year senior notes
|
| 9/13/2010 | IG | Market Commentary: Amgen, Symantec bring billion-dollar deals as offerings stack up; HP, Dell 10 bps better
|
| 9/13/2010 | CVIG | S&P rates Amgen notes A+
|
| 9/13/2010 | CVIG | Moody's rates Amgen notes A3
|
| 6/4/2010 | CVIG | Moody's: Amgen outlook positive
|
| 3/9/2010 | IG | New Issue: Amgen sells $1 billion of senior notes in 10-, 30-year tranches
|
| 3/9/2010 | IG | Market Commentary: Novartis, Amgen, Anadarko, ProLogis, RBS among IG issuers; new deals firm in busy trading day
|
| 3/9/2010 | CVIG | S&P assigns Amgen notes A+
|
| 3/9/2010 | CVIG | Moody's gives Amgen notes A3
|
| 3/9/2010 | CVIG | Fitch affirms Amgen
|
| 2/20/2009 | CVIG | Fitch affirms Amgen
|
| 1/14/2009 | IG | New Issue: Amgen gives terms for $2 billion of notes in 10-, 30-year tranches
|
| 1/14/2009 | IG | Market Commentary: High volume continues: CSX, Pepsi unit, Campbell Soup, R.R. Donnelley, Morgan Stanley price
|
| 1/13/2009 | CVIG | S&P rates Amgen notes A+
|
| 1/13/2009 | CVIG | Fitch gives Amgen notes A
|
| 1/13/2009 | CVIG | Moody's gives Amgen notes A3
|
| 1/13/2009 | IG | New Issue: Amgen prices $2 billion of notes in 10-, 30-year tranches
|
| 1/13/2009 | IG | Market Commentary: Hectic day sees FedEx, Amgen, Reed Elsevier, McDonald's, Goldman, others price; Citi, Morgan Stanley wider
|
| 8/13/2008 | CVIG | S&P: Amgen outlook stable
|
| 5/29/2008 | IG | S&P: Amgen unaffected
|
| 5/21/2008 | IG | Market Commentary: ING, ILFC, Liberty Mutual, NYSE price; Amgen takes opportunity to go long; secondary softens
|
| 5/20/2008 | IG | New Issue: Amgen prices $1 billion senior notes in 10-, 30-year tranches
|
| 5/20/2008 | IG | Market Commentary: Amgen, Bank of America, American Express unit price; low new issue premiums cause secondary woes
|
| 5/20/2008 | CVIG | S&P gives Amgen notes A+
|
| 5/20/2008 | CVIG | Moody's gives Amgen notes A3
|
| 5/20/2008 | CVIG | Fitch rates Amgen notes A
|
| 5/13/2008 | IG | Moody's cuts Amgen
|
| 4/17/2008 | CVIG | Amgen files automatic shelf registration
|
| 3/17/2008 | IG | Moody's may cut Amgen
|
| 12/21/2007 | CVIG | Moody's rates Amgen loan A2
|
| 9/7/2007 | CVIG | S&P affirms Amgen
|
